Comparison of Tenofovir, Zidovudine, or Stavudine as Part of First-Line Antiretroviral Therapy in a Resource-Limited-Setting A Cohort Study.docVIP

ComparisonofTenofovir,Zidovudine,orStavudineas PartofFirst-LineAntiretroviralTherapyinaResource- Limited-Setting:ACohortStudy KavindhranVelen1,JamesJ.Lewis1,2,SalomeCharalambous1,AlisonD.Grant2,GavinJ.Churchyard1,2, ChristopherJ.Hoffmann1,3 * 1TheAurumInstitute,Johannesburg,SouthAfrica,2LondonSchoolofHygieneandTropicalMedicine,London,UnitedKingdom,3DivisionofInfectiousDiseases,Johns HopkinsUniversitySchoolofMedicine,Baltimore,Maryland,UnitedStatesofAmerica Abstract Background: Tenofovir (TDF) is part of theWHO recommended first-line antiretroviral therapy (ART); however, thereare limiteddata